JNJ-1245

N/A

Report date: 2025/01/26 18:06:19
NME

Base Information

Drug NameJNJ-1245
Drug Alias NameMcl-1 inhibitors (Janssen Pharmaceutica NV)JNJ-1245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NV
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A